Ignite Creation Date:
2024-05-06 @ 2:38 AM
Last Modification Date:
2024-10-26 @ 11:21 AM
Study NCT ID:
NCT02098967
Status:
COMPLETED
Last Update Posted:
2018-05-17
First Post:
2014-03-25
Brief Title:
A Study of the Safety and Pharmacokinetics of RO6839921 An MDM2 Antagonist in Patients With Advanced Cancers Including Acute Myeloid Leukemia
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoplasms Myelogenous Leukemia Acute |
Keywords: